Biotech

All Articles

Repare lays off 25% of personnel as biotech stops preclinical R&ampD

.Repare Therapeutics is actually giving up a fourth of its own workforce as the oncology biotech les...

J &amp J files for FDA confirmation of $6.5 B autoimmune medication

.Johnson &amp Johnson has gotten another action toward recognizing a return on its $6.5 billion nipo...

Gain's period 1 win leads technique to show Parkinson's drug's worth

.Gain Therapeutics has specified its own direct showing the efficiency of its Parkinson's ailment th...

Actinogen reports brand-new phase 2 data to recover anxiety medication

.Actinogen Medical's chances-- and supply cost-- have actually recoiled somewhat coming from earlier...

Pfizer and also Flagship include Ratio to multibillion-dollar formula

.Flagship Pioneering as well as Pfizer have included Quotient in to their 10-program relationship, i...

Bayer markers $547M deal to push boundaries of noncoding RNA

.Bayer executives were eager to stress and anxiety to Tough this summertime that the German pharma g...

UK unveils plans to introduce 18 brand-new clinical test hubs

.Among a yearslong medical test downtrend in the U.K., a brand new public-private collaboration has ...

UPDATE: Genentech telegrams 93 unemployments in California after sharing plans to shutter cancer cells immunology research study unit

.Adhering to the statement of a huge discharge shot in April as well as a major restructuring projec...

Neurocrine's KarXT opponent attacks in period 2-- yet just at reduced dosage

.Neurocrine Biosciences has accomplished its own hoped-for profile page in a period 2 mental illness...

Vaderis' uncommon blood vessel disorder medication lessens nosebleeds

.Vaderis Rehabs' goal to develop the initial medication aimed especially at a certain rare blood ves...